eXoZymes, Inc. EXOZ
4.11 USD -0.20 (-4.64%)
At closeNov 5, 2026, 4:00 PM EST
4.75 +0.64 +15.57%
After hours · Nov 5, 4:00 PM ET
4.11 Day range 4.89
3.24 52-week range 18.40
- YTD
- -62.29%
- 1 year
- -69.56%
- Market cap
- 38.24M
- EPS (ttm)
- -1.19
- YTD return
- -62.29%
- 1-year return
- -69.56%
- Volume
- 7.36K
- Avg volume
- 8.40K
- Open
- 4.60
- Previous close
- 4.31
- Day's range
- 4.11 – 4.89
- 52-week range
- 3.24 – 18.40
2Y -4.54 (-52.49%)
Financials — quick view
EXOZ Revenue — quarterly 0
EXOZ Net income — quarterly -2.88M
EXOZ EPS — quarterly -0.33
News
eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research 
Water Tower Research Publishes Initiation of Coverage Report on eXoZymes, Inc., "Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity" 
Head to Head Contrast: Iovance Biotherapeutics (NASDAQ:IOVA) vs. eXoZymes (NASDAQ:EXOZ) 
12 Health Care Stocks Moving In Wednesday's After-Market Session 
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT 
eXoZymes Q2 Earnings Call Highlights 
eXoZymes Q2 Earnings Call Highlights 
12 Health Care Stocks Moving In Thursday's After-Market Session 
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today 
eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets
Your note
Sign in to keep a note on EXOZ — it syncs with the Stock Master app.